Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China flag China · Delayed Price · Currency is CNY
8.02
-0.04 (-0.50%)
Sep 4, 2026, 3:00 PM CST

SHA:600867 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,2831,219-41.951,1681,5821,308
Depreciation & Amortization
280.62269.55189.01185.87151.17143.65
Other Amortization
30.9131.4416.03-0.55--
Loss (Gain) From Sale of Assets
3.633.12-15.13-0-0.19-7.71
Asset Writedown & Restructuring Costs
251.08259.58335.7810.132.0423.04
Loss (Gain) From Sale of Investments
-1,153-1,180-123.31-92.45-930.32-296.88
Provision & Write-off of Bad Debts
-3.84-3.84-15.5920.12-7.412.26
Other Operating Activities
16.1812.6935.6712.49-6.6510.31
Change in Accounts Receivable
0.7185.45319.11-430.93140.57-88.27
Change in Inventory
60.4920.37-48.51-55.53-124.65-3.41
Change in Accounts Payable
86.9-100.33-89.0136.9952.9393.84
Operating Cash Flow
894.07689.23462.33861.52863.091,180
Operating Cash Flow Growth
35.00%49.08%-46.34%-0.18%-26.88%-1.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-567.7-517.69-568.73-348.13-492.88-600.75
Sale of Property, Plant & Equipment
4.941.266.360.42-20.37
Cash Acquisitions
--0.15---
Investment in Securities
596.571,260-1002.5817.06544.82
Other Investing Activities
28.0841.9633.323.2219.8223.79
Investing Cash Flow
61.88785.13-568.92-321.99343.99-11.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-473840.25314.03--
Total Debt Issued
494.75473840.25314.03--
Long-Term Debt Repaid
--656.1-447.03-40--
Lease Payments
-7.21-7.21-2.99---
Total Debt Repaid
-725.6-656.1-447.03-40--
Net Debt Issued (Repaid)
-230.85-183.1393.22274.03--
Issuance of Common Stock
-8.7321.45---
Repurchase of Common Stock
-27.6-27.6-300.28---
Common Dividends Paid
-603.96-505.28-505.79-496.25-1,096-425.04
Other Financing Activities
64.3867.82-16.36-1.74-188.28-270.56
Financing Cash Flow
-798.03-639.44-407.76-223.95-1,284-695.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.070.070.340.570-0
Net Cash Flow
157.98834.98-514.01316.14-76.98473.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
326.36171.53-106.4513.4370.21579.62
Free Cash Flow Growth
45.55%--38.68%-36.13%-18.67%
Free Cash Flow Margin
10.52%5.82%-5.29%16.69%13.32%17.74%
Free Cash Flow Per Share
0.170.09-0.050.260.180.28
Levered Free Cash Flow
-270.66245.43-133.47372.52187.64347.72
Unlevered Free Cash Flow
-257.02259.07-124.48375.76187.81347.72
Free Cash Flow After Leases
319.16164.33-109.39513.4370.21579.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---1.66--
Cash Income Tax Paid
436.46414.03166.03219.83284.18217.64
Change in Working Capital
185.3377.4581.82-441.9272.56-2.56